Our cases with pulmonary alveolar proteinosis

G. Okumus (Istanbul, Turkey), Z. Bingol (Istanbul, Turkey), G. Öcal (Istanbul, Turkey), E. Kiyan (Istanbul, Turkey)

Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Okumus (Istanbul, Turkey), Z. Bingol (Istanbul, Turkey), G. Öcal (Istanbul, Turkey), E. Kiyan (Istanbul, Turkey). Our cases with pulmonary alveolar proteinosis. 3018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
PAS-negative pulmonary alveolar proteinosis
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008

Pulmonary alveolar proteinosis
Source: Eur Respir Rev 2011; 20: 98-107
Year: 2011



Pulmonary alveolar proteinosis
Source: Eur Respir Mon; 2009: 46: 208–224
Year: 2009

Lung cysts in pulmonary alveolar proteinosis.
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018

Pulmonary alveolar proteinosis, study of 29 cases
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010

Pulmonary alveolar proteinosis
Source: Respipedia Article
Year: 2017

Pulmonary alveolar proteinosis: report of two cases
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009


Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis
Source: International Congress 2019 – CCC Airway diseases
Year: 2019



The benefits of whole lung lavage in pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 23: 503-505
Year: 2004


The role of apoptosis in idiopathic pulmonary alveolar proteinosis
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006


Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP)
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020


Pulmonary alveolar proteinosis: from classification to therapy
Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020
Year: 2020



Possible ocular involvement in pulmonary alveolar proteinosis
Source: Eur Respir J 2006; 28: 456
Year: 2006


Pulmonary alveolar proteinosis and GM/CSF antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 30s
Year: 2005

Abnormal intraalveolar accumulation of surfactant proteins in adults with pulmonary alveolar proteinosis
Source: Eur Respir J 2002; 20: Suppl. 38, 90s
Year: 2002

Alveolar proteinosis
Source: Annual Congress 2004 - Update on rare diffuse lung diseases
Year: 2004

Surfactant proteins in pulmonary alveolar proteinosis in adults
Source: Eur Respir J 2004; 24: 426-435
Year: 2004



Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004